Caravan Biologix

Caravan Biologix

Biotechnology Research

Princeton , NJ 280 followers

A New Paradigm in Oncology and Hereditary Disease Therapeutics - The First AI Designed Mini-CAR Therapeutic

About us

CAR-Directed BioSpheres (Mini-CAR) are innovative therapeutic agents that emulate the functions of T cells, Natural Killer cells, or macrophages. These miniaturized biospheres, derived from an allogeneic parent cell, house chimeric antigen receptors (CARs) and optional checkpoint inhibition tags. This unique design enables highly targeted and safe release of apoptotic proteins to diseased cells, offering a promising solution to the limitations of conventional CAR whole cell therapies in treating a variety of diseases, including solid tumor cancers and hereditary disease.

Website
www.caravanbio.com
Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Princeton , NJ
Type
Privately Held
Founded
2020
Specialties
CAR for solid tumors, mini-CAR, AI, Gene Editing, Infectious Diseases, Biologics, Chimeric Antigen Receptors, Rare Diseases, and Longevity

Locations

Employees at Caravan Biologix

Updates

Similar pages

Browse jobs

Funding

Caravan Biologix 1 total round

Last Round

Seed

US$ 1.7M

See more info on crunchbase